PRDM16 and achalasia-alacrima syndrome: Importantly, several preclinical studies have suggested a role for PRDM16 in the initiation/progression of arterial-restricted diseases, such as atherosclerosis, coronary artery disease (CAD), and abdominal aortic aneurysms (AAAs).